Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality (vol 24, pg 256, 2022)

NGUYEN, Thanh N, Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER, Robert MIKULÍK, Anvitha SATHYA, Ossama Yassin MANSOUR, Anna CZLONKOWSKA, Hannah LO, Thalia S FIELD, Andreas CHARIDIMOU, Soma BANERJEE, Shadi YAGHI, James E SIEGLER, Petra ŠEDOVÁ, Joseph KWAN, de Sousa Diana AGUIAR, Jelle DEMEESTERE, Violiza INOA, Setareh Salehi OMRAN, Liqun ZHANG, Patrik MICHEL, Davide STRAMBO, Joao Pedro MARTO a Raul G NOGUEIRA. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality (vol 24, pg 256, 2022). JOURNAL OF STROKE. SEOUL: KOREAN STROKE SOC, 2024, roč. 26, č. 1, s. 129. ISSN 2287-6391. Dostupné z: https://dx.doi.org/10.5853/jos.2022.00752.

Základní údaje

• Originální název: Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality (vol 24, pg 256, 2022)
• Autoři: NGUYEN, Thanh N, Muhammad M QURESHI, Piers KLEIN, Hiroshi YAMAGAMI, Mohamad ABDALKADER, Robert MIKULÍK (203 Česká republika, domácí), Anvitha SATHYA, Ossama Yassin MANSOUR, Anna CZLONKOWSKA, Hannah LO, Thalia S FIELD, Andreas CHARIDIMOU, Soma BANERJEE, Shadi YAGHI, James E SIEGLER, Petra ŠEDOVÁ (203 Česká republika, domácí), Joseph KWAN, de Sousa Diana AGUIAR, Jelle DEMEESTERE, Violiza INOA, Setareh Salehi OMRAN, Liqun ZHANG, Patrik MICHEL, Davide STRAMBO, Joao Pedro MARTO a Raul G NOGUEIRA.
• Vydání: JOURNAL OF STROKE, SEOUL, KOREAN STROKE SOC, 2024, 2287-6391.

Další údaje

• Originální jazyk: angličtina
• Typ výsledku: Článek v odborném periodiku
• Obor: 30210 Clinical neurology
• Stát vydavatele: Korejská republika
• Utajení: není předmětem státního či obchodního tajemství
• WWW: URL
• Impakt faktor: Impact factor: 8.200 v roce 2022
• Organizační jednotka: Lékařská fakulta
• Doi: http://dx.doi.org/10.5853/jos.2022.00752
• UT WoS: 001203679600005
• Klíčová slova anglicky: COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; Stroke
• Štítky: 14110127, 14110132
• Příznaky: Mezinárodní význam, Recenzováno

Anotace

Background and Purpose Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). Results There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths. Conclusions During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT.

Návaznosti

• LM2018128, projekt VaV: Název: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Akronym: CZECRIN)

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Český národní uzel Evropské sítě infrastruktur klinického výzkumu (CZECRIN)